These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6658706)

  • 21. Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes.
    Bilezikian SB; Nossel HL; Butler VP; Canfield RE
    J Clin Invest; 1975 Aug; 56(2):438-45. PubMed ID: 50328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrinogen Seattle II: congenital dysfibrinogenemia with an Arg (A alpha 16)----his substitution.
    Ebert RF; Schreiler WE; Bell WR
    Thromb Res; 1986 Jul; 43(1):7-13. PubMed ID: 3726812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombin-induced fibrinopeptide release from a fibrinogen variant (fibrinogen Sydney I) with an Aalpha Arg-16----His substitution.
    Southan C; Lane DA; Bode W; Henschen A
    Eur J Biochem; 1985 Mar; 147(3):593-600. PubMed ID: 3979390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrinogen survival and fibrinopeptide A in acute leukemia.
    Castaman G; Galloni E; Dri AV; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fibrinogen Zürich I: defective fibrinopeptide-A release].
    Hofmann V; Gati WP; Straub PW
    Schweiz Med Wochenschr; 1977 Oct; 107(41):1468. PubMed ID: 918602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of activation of prothrombin by streptokinase compared with urokinase and tissue-type plasminogen activator (t-PA).
    Eisenberg PR; Miletich JP; Sobel BE; Jaffe AS
    Thromb Res; 1988 Jun; 50(5):707-17. PubMed ID: 3137687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease.
    Yoda Y; Abe T
    Thromb Haemost; 1981 Dec; 46(4):706-9. PubMed ID: 7330820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High fibrinopeptide A (FPA) levels in acute non-lymphocytic leukemia are reduced by heparin administration.
    Gugliotta L; Viganò S; D'Angelo A; Guarini A; Tura S; Mannucci PM
    Thromb Haemost; 1984 Dec; 52(3):301-4. PubMed ID: 6531754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between elevated fibrinopeptide A levels and alpha-2-antiplasmin.
    Marongiu F; Mulas G; Mamusa AM; Mameli G; Marassi PP; Tronci MB; Cambuli AB; Acca MR; Balestrieri AA
    Haemostasis; 1987; 17(5):301-4. PubMed ID: 3666588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo behavior of fibrinogen fragment D in experimental renal, hepatic and reticuloendothelial dysfunction.
    Hayne OA; Sherman LA
    Am J Pathol; 1973 May; 71(2):219-38. PubMed ID: 4713941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity of antisera to human fibrinopeptide A used in clinical fibrinopeptide A assays.
    Nossel HL; Butler VP; Wilner GD; Canfield RE; Harfenist EJ
    Thromb Haemost; 1976 Feb; 35(1):101-9. PubMed ID: 60791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinopeptide A during normal pregnancy.
    Romero R; Rickles FR; Matthews E; Scott D; Dinan C; Duffy T
    Am J Perinatol; 1988 Jan; 5(1):70-3. PubMed ID: 3257391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrinogen Barcelona II: a new case of A alpha 16 Arg----His substitution.
    Borrell M; Vila L; Solá J; Coll I; Fontcuberta J
    Haemostasis; 1990; 20(1):1-7. PubMed ID: 2323678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin abolishes the chemotherapy-induced increase in plasma fibrinopeptide A levels.
    Edwards RL; Klaus M; Matthews E; McCullen C; Bona RD; Rickles FR
    Am J Med; 1990 Jul; 89(1):25-8. PubMed ID: 2368789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An in vitro evaluation of the hemostatic activity of topical agents.
    Eloy R; Baguet J; Christé G; Rissoan MC; Paul J; Belleville J
    J Biomed Mater Res; 1988 Feb; 22(2):149-57. PubMed ID: 3356713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits.
    Speidel CM; Eisenberg PR; Ruf W; Edgington TS; Abendschein DR
    Circulation; 1995 Dec; 92(11):3323-30. PubMed ID: 7586321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of fibrinopeptide release by thrombin as a function of CaCl2 concentration: different susceptibility of FPA and FPB and evidence for a fibrinogen isoform-specific effect at physiological Ca2+ concentration.
    Profumo A; Turci M; Damonte G; Ferri F; Magatti D; Cardinali B; Cuniberti C; Rocco M
    Biochemistry; 2003 Oct; 42(42):12335-48. PubMed ID: 14567695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of fibrinopeptide A in human blood.
    Nossel HL; Yudelman I; Canfield RE; Butler VP; Spanondis K; Wilner GD; Qureshi GD
    J Clin Invest; 1974 Jul; 54(1):43-53. PubMed ID: 4600045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution and elimination of intravenously injected urinary trypsin inhibitor.
    Jönsson-Berling BM; Ohlsson K
    Scand J Clin Lab Invest; 1991 Oct; 51(6):549-57. PubMed ID: 1767247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of heparin on plasma fibrinopeptide A in patients with acute myocardial infarction.
    Mombelli G; Im Hof V; Haeberli A; Straub PW
    Circulation; 1984 Apr; 69(4):684-9. PubMed ID: 6697455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.